Dual-targeting triplebody 33-16-123 (SPM-2) mediates effective redirected lysis of primary blasts from patients with a broad range of AML subtypes in combination with natural killer cells-Reference-Cited by-同舟云学术

Dual-targeting triplebody 33-16-123 (SPM-2) mediates effective redirected lysis of primary blasts from patients with a broad range of AML subtypes in combination with natural killer cells

Published:2018-07-30 Issue:9 Volume:7 Page:e1472195
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Braciak Todd A.¹,Roskopf Claudia C.¹,Wildenhain Sarah²,Fenn Nadja C.²,Schiller Christian B.²,Schubert Ingo A.³,Jacob Uwe⁴,Honegger Annemarie⁵^ORCID,Krupka Christina¹⁶,Subklewe Marion¹⁶,Spiekermann Karsten¹,Hopfner Karl-Peter²,Fey Georg H.³,Aigner Michael⁷,Krause Stefan⁷,Mackensen Andreas⁷,Oduncu Fuat S.¹

Affiliation:

1. Department of Hematology and Oncology, Medizinische Klinik und Poliklinik III, Klinikum der Universität München, Munich, Germany

2. Department of Biochemistry and Gene Center, Ludwig-Maximilians-Universität, Munich, Germany

3. Department of Biology, University of Erlangen-Nuremberg, Erlangen, Germany

4. Westend Innovation, Munich, Germany

5. Department of Biochemistry, University of Zurich, Zurich, Switzerland

6. Laboratory of Translational Cancer Immunol ogy, Gene Center of the LMU Munich, Munich, Germany

7. Department of Internal Medicine 5 - Hematology/Oncology, University of Erlangen-Nuremberg, Erlangen, Germany

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2018.1472195

Reference83 articles.

1. An update of current treatments for adult acute myeloid leukemia

2. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

3. Tracing the origins of relapse in acute myeloid leukaemia to stem cells

4. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

5. Stem cell concepts renew cancer research

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breaking Boundaries: Immunotherapy for Myeloid Malignancies;Cancers;2024-08-06

2. Dual-targeting CD33/CD123 NANOBODY T-cell engager with potent anti-AML activity and good safety profile;Blood Advances;2024-04-26

3. The present and future of bispecific antibodies for cancer therapy;Nature Reviews Drug Discovery;2024-03-06

4. Bi- and trispecific immune cell engagers for immunotherapy of hematological malignancies;Journal of Hematology & Oncology;2023-07-27

5. When three is not a crowd: trispecific antibodies for enhanced cancer immunotherapy;Theranostics;2023